FDA.reportPublic FDA data

510(k) K221842

Device
Elecsys B-Amyloid (1-42) CSF II, Elecsys Phospho-Tau (181P) CSF
Applicant
Roche Diagnostics
510(k) number
K221842
Product code
QSE  
Decision
Substantially Equivalent (SESE)
Decision date
2022-12-07
Date received
2022-06-24
Regulation
866.5840
Classification name
Alzheimer’s Disease Pathology Assessment Test
Medical specialty
Immunology
Review panel
Immunology
Device class
2
Clearance type
Traditional
Statement or summary
Summary
Third party reviewed
No

Applicant Contact#

Contact
Greg Mondics
Address
9115 Hague Rd. Indianapolis IN US 46250 46250

FDA Registration Numbers#

Source Documents#

510(k) summary PDF

Other 510(k) Records For Product Code QSE  #

510(k), Device, Applicant table
510(k)DeviceApplicantDecision date
K231348Elecsys ß-Amyloid (1-42) CSF II, Elecsys Total-Tau CSFRoche Diagnostics2023-06-05
DEN200072Lumipulse G ß-Amyloid Ratio (1-42/1-40)Fujirebio Diagnostics,Inc.2022-05-04

Legacy Summary#

Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links Follow FDA En Español Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products FDA Home Medical Devices Databases

FDA Review#

Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links Follow FDA En Español Home Food Drugs Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products FDA Home Medical Devices Databases